» Articles » PMID: 23014338

Global Epidemiology of Psoriasis: a Systematic Review of Incidence and Prevalence

Overview
Publisher Elsevier
Specialty Dermatology
Date 2012 Sep 28
PMID 23014338
Citations 832
Authors
Affiliations
Soon will be listed here.
Abstract

The worldwide incidence and prevalence of psoriasis is poorly understood. To better understand this, we performed a systematic review of published population-based studies on the incidence and prevalence of psoriasis. Three electronic databases were searched from their inception dates to July 2011. A total of 385 papers were critically appraised; 53 studies reported on the prevalence and incidence of psoriasis in the general population. The prevalence in children ranged from 0% (Taiwan) to 2.1% (Italy), and in adults it varied from 0.91% (United States) to 8.5% (Norway). In children, the incidence estimate reported (United States) was 40.8/100,000 person-years. In adults, it varied from 78.9/100,000 person-years (United States) to 230/100,000 person-years (Italy). The data indicated that the occurrence of psoriasis varied according to age and geographic region, being more frequent in countries more distant from the equator. Prevalence estimates also varied in relation to demographic characteristics in that studies confined to adults reported higher estimates of psoriasis compared with those involving all age groups. Studies on the prevalence and incidence of psoriasis have contributed to a better understanding of the burden of the disease. However, further research is required to fill existing gaps in understanding the epidemiology of psoriasis and trends in incidence over time.

Citing Articles

miR-16-5p, miR-21-5p, and miR-155-5p in circulating vesicles as psoriasis biomarkers.

Guzman-Martin C, Jimenez-Ortega R, Ortega-Springall M, Pena-Pena M, Guerrero-Ponce A, Vega-Memije M Sci Rep. 2025; 15(1):6971.

PMID: 40011539 PMC: 11865590. DOI: 10.1038/s41598-025-91532-9.


Association Between Systemic Inflammation, Metabolic Syndrome and Quality of Life in Psoriasis Patients.

Mustata M, Neagoe C, Radulescu V, Dragne I, Cimpeanu R, Radu L Life (Basel). 2025; 15(2).

PMID: 40003621 PMC: 11856174. DOI: 10.3390/life15020212.


Beyond the dichotomy: understanding the overlap between atopic dermatitis and psoriasis.

Li M, Wang J, Liu Q, Liu Y, Mi W, Li W Front Immunol. 2025; 16:1541776.

PMID: 39995673 PMC: 11847814. DOI: 10.3389/fimmu.2025.1541776.


Identification of Tie2 as a sensor for reactive oxygen species and its therapeutic implication.

Pham A, Na Y, Suk G, Yang C, Kang S, Lee J Redox Biol. 2025; 81:103555.

PMID: 39993340 PMC: 11903958. DOI: 10.1016/j.redox.2025.103555.


Benefits and Satisfaction with Apremilast Treatment in Patients with Psoriasis Affecting the Genital Area: Secondary Analysis of the APPRECIATE Study.

da Silva Burger N, Tran K, Typou M, Sommer R, Neasham D, Cordey M Dermatol Ther (Heidelb). 2025; 15(3):681-695.

PMID: 39969771 DOI: 10.1007/s13555-025-01360-y.